About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
98.85
NSE Code
GLAXO
Dividend Yield %
1.40
Market Cap
387008.08
P/E
57.86
EPS
39.49
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2024
2023
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
20-Dec-2024
2104
1027
48.81
19-Dec-2024
3135
1545
49.28
18-Dec-2024
3765
1493
39.65
17-Dec-2024
4872
2823
57.94
16-Dec-2024
8335
5568
66.80
13-Dec-2024
3421
1778
51.97
12-Dec-2024
2393
1443
60.30
11-Dec-2024
2635
1325
50.28
10-Dec-2024
3398
1966
57.86
09-Dec-2024
2327
1215
52.21
06-Dec-2024
1939
1131
58.33
05-Dec-2024
1154
578
50.09
04-Dec-2024
1425
693
48.63
03-Dec-2024
3097
1716
55.41
02-Dec-2024
3705
1725
46.56
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.